colchicine has been researched along with Carcinoma, Non-Small Cell Lung in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CY; Chang, JY; Chen, MC; Hsu, KC; Lai, MJ; Lee, HY; Lin, MH; Lin, TE; Liou, JP; Liu, YM; Nepali, K; Ojha, R | 1 |
| Chang, X; Guan, Q; Hao, M; Huang, L; Li, Z; Liu, Z; Shi, Y; Wu, Y; Yang, Y; Zhang, W; Zhou, T; Zuo, D | 1 |
| Cai, YD; Chen, L; Huang, T; Kong, X; Yang, J; Zheng, M | 1 |
| Laterra, J; Pomper, MG; Zhang, Y | 1 |
| Awasthi, S; Awasthi, YC; Sharma, R; Singhal, SS; Wickramarachchi, D | 1 |
| Chao, CC; Chiang, CD; Song, EJ; Yang, VC | 1 |
| Baptiste, N; Chen, X; Friedlander, P; Prives, C | 1 |
7 other study(ies) available for colchicine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase.
Topics: A549 Cells; Animals; Antineoplastic Agents; Benzamides; Carcinoma, Non-Small-Cell Lung; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Heterografts; Histone Deacetylase Inhibitors; Humans; Indoles; Lymphoma, B-Cell; Mice; Models, Molecular; Protein Binding; Tubulin Modulators | 2019 |
A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non-small cell lung cancers.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Colchicine; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Mice; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2022 |
The Use of Chemical-Chemical Interaction and Chemical Structure to Identify New Candidate Chemicals Related to Lung Cancer.
Topics: Animals; Antineoplastic Agents; Arsenicals; Berberine; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Colchicine; Daunorubicin; Digoxin; Drug Discovery; Humans; Lung; Lung Neoplasms; Ouabain; Prednisone; Small Cell Lung Carcinoma; Tretinoin | 2015 |
Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp.
Topics: Anilides; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzimidazoles; Carcinoma, Non-Small-Cell Lung; Cells, Cultured; Colchicine; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Hedgehog Proteins; Humans; Lung Neoplasms; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pyridines; Signal Transduction | 2009 |
RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; ATP-Binding Cassette Transporters; Biological Transport; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Line, Tumor; Colchicine; Drug Resistance, Neoplasm; Electrophoresis, Polyacrylamide Gel; GTPase-Activating Proteins; HL-60 Cells; Humans; Leukotriene C4; Mass Spectrometry; Phosphorylation; Protein Kinase C; U937 Cells | 2004 |
Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells.
Topics: Ascorbic Acid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cisplatin; Colchicine; Dactinomycin; Doxorubicin; Drug Resistance; Gene Expression; Humans; Lung Neoplasms; Membrane Glycoproteins; Tumor Cells, Cultured; Vinblastine; Vincristine | 1994 |
The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Clone Cells; Colchicine; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Daunorubicin; DNA Damage; DNA, Neoplasm; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Lung Neoplasms; Models, Biological; Proline; Promoter Regions, Genetic; Protein Structure, Tertiary; Recombinant Fusion Proteins; Structure-Activity Relationship; Tetracycline; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |